Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.83M | -23.42M | -6.61M | -18.96M | -11.53M |
| Total Depreciation and Amortization | 6.00M | 6.11M | 6.04M | 6.05M | 5.92M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.16M | 10.87M | 9.29M | 21.25M | 10.97M |
| Change in Net Operating Assets | 16.76M | -71.71M | 2.38M | -38.52M | -9.79M |
| Cash from Operations | 7.10M | -78.14M | 11.11M | -30.17M | -4.43M |
| Capital Expenditure | -5.20M | -4.98M | -6.05M | -6.83M | -4.72M |
| Sale of Property, Plant, and Equipment | 8.00K | 0.00 | 3.00K | 0.00 | 2.00K |
| Cash Acquisitions | -55.57M | 0.00 | 3.78M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.70M | 16.13M | 21.36M | 60.23M | 32.45M |
| Cash from Investing | 10.94M | 11.15M | 19.08M | 53.40M | 27.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -564.00K | -88.00K | -88.00K | -88.00K | -606.00K |
| Issuance of Common Stock | 9.00K | 1.00K | -- | -- | -- |
| Repurchase of Common Stock | -44.28M | -447.00K | -357.00K | -2.55M | -10.57M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -44.83M | -534.00K | -445.00K | -2.64M | -11.17M |
| Foreign Exchange rate Adjustments | 3.00K | 75.00K | 15.00K | 4.00K | 11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.79M | -67.45M | 29.76M | 20.60M | 12.14M |